Prostate Cancer Newsfeed

… gold standard for cancer treatment.' Prostate cancer is the … every year, according to Prostate Cancer UK.  The research, … IS PROSTATE CANCER? How many people does it kill? Prostate cancer became … dying of breast cancer. It means prostate cancer is behind …

… diagnosed every year, according to Prostate Cancer UK. Professor Johann de Bono … often and with ease. “Tracking prostate cancer with a blood test instead … as Cancer Research UK, Prostate Cancer UK, the Movember Foundation and the Prostate Cancer Foundation …

… treatment for metastatic castration-resistant prostate cancer (mCRPC). Forma’s sickle cell … rare blood disorder. Forma’s prostate cancer treatment is designed to inhibit … the androgen receptor, which drives prostate cancer cell growth. The FDA in …

… of men with recurrent prostate cancer after radiotherapy, the options … a treatment for their cancer that does not carry … Paul Sayer, from the UK prostate cancer charity Prost8,  who himself … local hospital following a prostate cancer diagnosis will only be …

… ongoing battle against stage 4 prostate cancer. With encouragement from his doctor … received his diagnosis of metastatic prostate cancer. “Basically, I got 32 months … him look not so crazy.” Prostate cancer is the second-most common …

… patients with metastatic castration-resistant prostate cancer (mCRPC) who have failed … treatment for hormone sensitive metastatic prostate cancer, despite rapid and dramatic … treating metastatic castration-resistant prostate cancer in a completely different …

… relugolix in men with advanced prostate cancer in an virtual presentation at …

… patients with metastatic castration-resistant prostate cancer (mCRPC) who have failed … treatment for hormone sensitive metastatic prostate cancer, despite rapid and dramatic … treating metastatic castration-resistant prostate cancer in a completely different …

… hormone-sensitive prostate cancer (mHSPC), a form of prostate cancer that has … metastatic Hormone-Sensitive Prostate Cancer (mHSPC) In men with prostate cancer, the disease … ;/www.cancer.net/cancer-types/prostate-cancer/types-treatment …

May 29 (Reuters) - Astellas Pharma Inc: * FINAL PROSPER RESULTS SHOW XTANDI SIGNIFICANTLY EXTENDS OVERALL SURVIVAL IN MEN WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER Source text for Eikon: Further company coverage:

… (enzalutamide) for the treatment of prostate cancer patients with distant metastases. Previously … was approved for castration-resistant prostate cancer. The company has global ex …

… quarter of 2020.  About Prostate Cancer Prostate cancer is the second most prevalent … diagnosed in 2019. Advanced prostate cancer is prostate cancer that has spread or … disease. Treatment for advanced prostate cancer typically involves androgen deprivation …

… of mCRPC (metastatic castration-resistant prostate cancer) cases have mutations in certain … to develop precision medications for prostate cancer. The PCF Team quickly … FDA “Breakthrough Therapy Designation” in prostate cancer. Rucaparib’s approval is based …

… with metastatic castration-resistant prostate cancer. ARV-110 has demonstrated … -Resistant Prostate Cancer (mCRPC) In the United States, prostate cancer is … diagnosed with prostate cancer in his lifetime. Metastatic castration-resistant prostate cancer (mCRPC …

… cancer deaths – more than those from colorectal, breast and prostate … for Research on Cancer. 2018 Lung Cancer Fact Sheet. Available … 47;/www.cancer.org/cancer/lung-cancer/about… #47;/www.cancer.org/cancer/lungcancer-non-smallcell …

… complex sugars to detect prostate cancer earlier and with greater … , Director of Research at Prostate Cancer UK, said: “Early … and accurate diagnosis of prostate cancer is critical to ensuring … coming to a standstill, Prostate Cancer UK is asking for …

… treatment for advanced hormone dependent prostate cancer and works by decreasing the … can fuel the growth of prostate cancer so this medication temporarily suppresses … ., with a vast expertise in prostate cancer treatment and Robotic-Assisted Laparoscopic …

May 28 (Reuters) - Clovis Oncology Inc: * CLOVIS ONCOLOGY - ANNOUNCES NEW RECOMMENDATIONS FOR RUBRACA FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER Source text for Eikon: Further company coverage:

… -DAILY, ORAL RELUGOLIX IN ADVANCED PROSTATE CANCER AND PUBLICATION IN THE NEW …

… Hospital Patients suspected of having cancer are not getting appointments or … has a family history of prostate cancer, had an MRI scan in … two-centimetre lesion on his prostate that he said he was … being told they may have cancer, BBC Midlands Today's …

… 21% of patients, followed by prostate, gastrointestinal, and thoracic, including lung … Warner says. “Patients with progressing cancer or impaired performance are at … treatments, with guidance from their cancer specialists, infectious disease specialists, and …

… living with breast cancer,” said Albert Bourla … advanced or metastatic breast cancer in combination with … advanced or metastatic breast cancer in combination with … cancer medicines and biosimilars across more than 30 indications, including breast, prostate …

Accelerating Efforts to Address the Prostate Cancer Racial Disparity With Church Partners A panel discussion outlining strategies to accelerate support for African American communities in the fight against prostate cancer during and beyond COVID-19.

… commercialization of novel targeted cancer therapeutics and utilizing a … trial in biliary tract cancer.  3D Medicines and Alphamab … develops targeted therapies for cancer utilizing a capital efficient … of the treatment of prostate cancer; TRC102, a small …

… coronavirus pandemic. LUNG CANCER Lung cancer kills more than 1 … 000 a month. PROSTATE CANCER Men with advanced prostate cancer often are treated … of death in men with prostate cancer, according to Dr. … has been disclosed. COLON CANCER Merck & Co.’s …